Home › Encyclopedia › Epithalon: Research Status, Identity, and Trial Data
Research / Unapproved

Epithalon: Research Status, Identity, and Trial Data

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC14H22N4O9
Molecular weight390.35 g/mol
Registered trials0
PubChem CID219042

Anyone researching epithalon will find little in the way of formal clinical data, and that gap matters. This overview lays out what is actually known about its chemical identity and trial footprint, without implying any proven use.

Key takeaways

  • Epithalon is classified as unapproved and has no FDA-reviewed drug label.
  • Its molecular formula is C14H22N4O9 with a molecular weight of 390.35.
  • No clinical trials for epithalon are currently registered in the dataset reviewed.
  • No adverse event reports are available for this compound at this time.

What epithalon is

Epithalon is a synthetic peptide compound identified by PubChem CID 219042. It is composed of four amino acid residues linked in a short chain, with the molecular formula C14H22N4O9. No FDA-approved label exists for this compound, so there is no established drug class, mechanism of action, or approved indication on file for it.

Trial footprint

The dataset reviewed shows zero registered clinical trials for epithalon. This means there is currently no clinical trial record, whether completed, ongoing, or planned, that can be cited for this compound.

FAQ

Is epithalon FDA approved?
No. Epithalon has no FDA-approved label, brand name, or approved indication. It is classified as an unapproved research compound.
What is epithalon chemically?
Epithalon is a synthetic peptide with the molecular formula C14H22N4O9 and a molecular weight of 390.35. It is identified in PubChem under CID 219042.
Are there clinical trials for epithalon?
The dataset reviewed shows no registered clinical trials for epithalon. There is currently no trial record available to describe its study phase or status.
Is there safety or side effect data for epithalon?
No adverse event reports were found for epithalon in the data reviewed. This means no report-based safety pattern can currently be summarized.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 219042 ClinicalTrials.gov search results FAERS query results

Updated 2026-08-03